Insulet (PODD)

• Market cap: $12.7B
• 1 day: -12.5%
• 5 days: -17.18%
• 1 month: -23.07%
• 3 months: -37.27%
• 6 months: -49.39%
• Year to date: -43.44%
• 1 year: -36.32%
• 5 years: -46.94%
• 10 years: 380.54%
• Sector: Healthcare
• Industry: Medical Devices

About: Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Employees: 5,400